Log in or Sign up for Free to view tailored content for your specialty!
Dermatology News
Dermatology pearls: Encourage sun protection, optimize steroids for cutaneous lupus
SAN DIEGO — While encouraging patients with cutaneous lupus erythematosus to use adequate sun protection, rheumatologists should be treating disease flares with more potent steroids then tapering off once other therapies are in progress, according to a presentation at the 2019 Congress of Clinical Rheumatology West.
Q&A: Psoriatic arthritis ‘not diagnosed enough’
Approximately 125 million people worldwide, including more than 8 million Americans, have psoriasis, according to the National Psoriasis Foundation. Between 10% and 30% of these patients will also develop psoriatic arthritis.
Log in or Sign up for Free to view tailored content for your specialty!
When Autoimmune Disease Strikes Thrice: Managing Multiple Autoimmune Syndrome
By the time Lilly Stairs was diagnosed with psoriatic arthritis at the age of 19 — following an arduous series of tests and doctor visits — she had already been living with an autoimmune disease for 12 years.
Personalized advice improves sun protection among patients
Patients who received individualized advice directly from their general practitioner improved their sun protection, according to findings from a randomized controlled study.
Women with chronic inflammatory diseases remain poorly informed of reproductive issues
Women of childbearing age with rheumatic diseases worldwide fail to receive appropriate information about the family planning and pregnancy continuum, according to findings presented at EULAR 2019. Healio Rheumatology took a closer look at the data and sat down with several key opinion leaders for a roundtable discussion to gain deeper understanding of how to resolve these issues.
Court ruling upholds Enbrel patent claim, blocks biosimilar rivals
A U.S. District Court judge has ruled in favor of Amgen in its lawsuit against Novartis’ Sandoz, which claimed patent infringement on its biologic etanercept by the biosimilar, etanercept-szzs.
Another summertime condition...
A healthy 14-year-old male presents with a rash on the sole of his left foot. He first noticed that there was something there 1 to 2 weeks earlier and that it was pruritic. There have been no other associated complaints, disturbing symptoms or fever. His past medical history is unremarkable, and his family history reveals no sick contacts or anyone else with skin or foot problems. His travel history, however, reveals that he spent 7 days at a tropical beach resort with his family. They had returned home about 1 week before the foot lesion was first noted.
Measles resurgence may pose unique threat to patients with inflammatory diseases
There have been nearly 1,100 measles cases in the United States in the first half of 2019 — more cases of measles than in any year since the disease was declared eliminated in the U.S. in 2000. As of July 25, 30 states have reported cases of measles, with outbreaks currently ongoing in five jurisdictions across the country.
Some systemic psoriasis treatments may be associated with UTI risk
The use of cyclosporine, infliximab and anti-IL17 in the treatment of psoriasis is associated with a higher risk for symptomatic urinary tract infection in women, according to a 10-year observational study.
FDA approves Hadlima, fourth Humira biosimilar
The FDA has approved the fourth biosimilar to adalimumab, adalimumab-bwwd, for all eligible indications of the biologic product, according to a company press release.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read